Publikationen, an denen er mitarbeitet Vicente Bertomeu González (26)

2024

  1. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

2022

  1. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    European Journal of Internal Medicine, Vol. 99, pp. 45-56

  2. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC Medicine, Vol. 20, Núm. 1

  3. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  4. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  5. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

  6. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

2021

  1. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  2. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    BMC Medicine, Vol. 19, Núm. 1

  3. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  4. The determinant effect of competing events in the analysis of heart failure incidence after myocardial infarction

    European Journal of Preventive Cardiology

2020

  1. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

2019

  1. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome

    International Journal of Cardiology, Vol. 276, pp. 20-25

2018

  1. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication

    International Journal of Cardiology, Vol. 270, pp. 36-41

2013

  1. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 103-109

2011

  1. Anticoagulation prescription in atrial fibrillation

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 10, pp. 1473-1479

  2. Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension

    Journal of Human Hypertension, Vol. 25, Núm. 10, pp. 600-607

  3. Differential effect of β-blockers for heart rate control in coronary artery disease

    Clinical Cardiology, Vol. 34, Núm. 12, pp. 748-754

  4. Factores asociados a la falta de control de la hipertensión arterial en pacientes con y sin enfermedad cardiovascular

    Revista Espanola de Cardiologia, Vol. 64, Núm. 7, pp. 587-593

  5. Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular

    Revista Espanola de Cardiologia, Vol. 64, Núm. 8, pp. 649-653